Haselmeier develops and supplies a new pen injector for insulin therapy that incorporates 3ml cartridges. The DIAPEN® – based on this platform– is launched in Germany and is still in use today by a specific pool of patients who specifically seek for a delivery experience not met by the most recent pen injectors.